ArticleCancer research communications2025

Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid Tumors.

Dazhi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.